經(jīng)皮去腎神經(jīng)術(shù):最新證據(jù)與患者篩選
【摘要】盡管有許多藥物和非藥物治療可降低血壓,但難治性高血壓仍是一個(gè)重要的健康問題。經(jīng)皮去腎神經(jīng)術(shù)(RDN)已成為有發(fā)展前景、臨床證據(jù)最多的用于改善血壓、提高血壓控制率的器械治療方法?,F(xiàn)總結(jié)目前RDN治療高血壓的機(jī)制,同時(shí)總結(jié)關(guān)于RDN的多項(xiàng)隨機(jī)假手術(shù)對照的臨床研究和優(yōu)化患者選擇。
【關(guān)鍵詞】高血壓;交感神經(jīng)系統(tǒng);去腎神經(jīng)術(shù)
【DOI】10.16806/j.cnki.issn.1004-3934.2024.03.005
Percutaneous Renal Denervation:Latest Evidence and Patient Selection
LI Yue,LU Chengzhi
(Tianjin First Central Hospital,Tianjin 300000,China)
【Abstract】Despite the existence of numerous pharmacological and non-pharmacological interventions for lowering blood pressure,refractory hypertension persists as a significant health concern.Renal denervation(RDN) has become a promising and clinically proven instrument therapy method for improving blood pressure and increasing blood pressure control.This review summarizes the current understanding of the mechanisms behind RDN in treating hypertension and provides an overview of several randomized sham-controlled clinical studies on RDN,as well as optimization of patient selection.
【Keywords】Hypertension;Sympathetic nervous system;Renal denervation
多年來,交感神經(jīng)系統(tǒng)與心血管疾病之間的關(guān)系早已為人所知,相關(guān)研究[1-3]探討了交感神經(jīng)系統(tǒng)活性增加與難治性高血壓之間的聯(lián)系。(剩余13966字)
-
-
- 心血管病學(xué)進(jìn)展
- 2024年03期
- 腎動(dòng)脈與高血壓...
- 腎動(dòng)脈狹窄介入治療中的血流動(dòng)力...
- 影像學(xué)在腎血管性高血壓評估中的...
- 高血壓相關(guān)的介入診療進(jìn)展...
- 經(jīng)皮去腎神經(jīng)術(shù):最新證據(jù)與患者...
- 經(jīng)皮去腎神經(jīng)術(shù)在非高血壓疾病治...
- 降脂藥物與認(rèn)知功能下降的研究進(jìn)...
- SGLT2抑制劑對射血分?jǐn)?shù)保留...
- CT及其衍生技術(shù)評價(jià)冠狀動(dòng)脈鈣...
- 心臟術(shù)后新發(fā)心房顫動(dòng)的研究進(jìn)展...
- 長鏈非編碼RNA調(diào)節(jié)自噬在心肌...
- 內(nèi)質(zhì)網(wǎng)應(yīng)激與內(nèi)皮功能障礙關(guān)系及...
- PCI后損傷血管再內(nèi)皮化的機(jī)制...
- 線粒體功能障礙與血管鈣化發(fā)生的...
- SIRT1介導(dǎo)的信號通路在阿霉...
- 鐵死亡的調(diào)控機(jī)制及其在蒽環(huán)類藥...
- 冠心病抗炎治療的臨床研究進(jìn)展...
- 青少年飲酒與成年早期高血壓...
- 高血壓數(shù)字化管理初探:FAIR...
- 尿液中性粒細(xì)胞明膠酶相關(guān)脂質(zhì)運(yùn)...